Tango Therapeutics, Inc. SEC filings TNGX
Tango Therapeutics, Inc. has 424 filings in SEC EDGAR's recent list, going back to Jul 30, 2020. Its latest annual report, Form ARS, was filed on Apr 17, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 23, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 23, 2026 | Oct 23, 2026 |
| 8-K |
Current report
Other events
|
Aug 11, 2026 | Aug 11, 2026 |
| 424B5 | Prospectus supplement | Aug 11, 2026 | — |
| 8-K |
Current report
Results of operations
|
Aug 11, 2026 | Aug 11, 2026 |
| 10-Q | Quarterly report | Aug 11, 2026 | Jun 30, 2026 |
| 8-K/A |
Amended current report
Officer or director change, Regulation FD disclosure
|
Aug 7, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 6, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 23, 2026 | Jun 19, 2026 |
| 8-K |
Current report
Material agreement
|
Jun 10, 2026 | Jun 9, 2026 |
| 424B5 | Prospectus supplement | Jun 10, 2026 | — |
| FWP | Free writing prospectus | Jun 10, 2026 | — |
| 424B5 | Prospectus supplement | Jun 8, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 8, 2026 | Jun 8, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 4, 2026 | Jun 4, 2026 |
| 8-K |
Current report
Results of operations, Officer or director change
|
May 13, 2026 | May 13, 2026 |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Officer or director change
|
May 8, 2026 | May 7, 2026 |
| ARS | Annual report to shareholders | Apr 17, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 17, 2026 | — |
| DEF 14A | Proxy statement | Apr 17, 2026 | Apr 16, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 15, 2026 | Apr 10, 2026 |
| S-8 | Employee stock plan registration | Mar 5, 2026 | — |
| 8-K |
Current report
Results of operations
|
Mar 5, 2026 | Mar 5, 2026 |
| 10-K | Annual report | Mar 5, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Jan 8, 2026 | Jan 7, 2026 |
| 8-K |
Current report
Officer or director change
|
Jan 5, 2026 | Jan 2, 2026 |
| EFFECT | Filing | Dec 10, 2025 | — |
| CORRESP | Letter to the SEC | Dec 8, 2025 | — |
| 8-K |
Current report
Material agreement, Agreement ended
|
Nov 21, 2025 | Nov 18, 2025 |
| S-3ASR | Automatic shelf registration | Nov 21, 2025 | — |
| S-3 | Shelf registration | Nov 21, 2025 | — |
| 8-K |
Current report
Results of operations
|
Nov 4, 2025 | Nov 4, 2025 |
| 10-Q | Quarterly report | Nov 4, 2025 | Sep 30, 2025 |
| D | Filing | Oct 28, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Oct 24, 2025 | Oct 23, 2025 |
| 424B5 | Prospectus supplement | Oct 24, 2025 | — |
| FWP | Free writing prospectus | Oct 23, 2025 | — |
| 8-K |
Current report
Results of operations, Other events
|
Oct 23, 2025 | Oct 23, 2025 |
| 8-K |
Current report
Officer or director change
|
Aug 25, 2025 | Aug 21, 2025 |
| 10-Q | Quarterly report | Aug 5, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2025 | Aug 5, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 6, 2025 | Jun 5, 2025 |
| EFFECT | Filing | May 21, 2025 | — |
| UPLOAD | Letter from the SEC | May 20, 2025 | — |
| CORRESP | Letter to the SEC | May 19, 2025 | — |
| S-3 | Shelf registration | May 12, 2025 | — |
| 10-Q | Quarterly report | May 12, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 12, 2025 | May 12, 2025 |
| DEFR14A | Filing | Apr 24, 2025 | — |
| ARS | Annual report to shareholders | Apr 22, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 22, 2025 | — |
| DEF 14A | Proxy statement | Apr 21, 2025 | Apr 21, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 11, 2025 | Apr 11, 2025 |
| S-8 | Employee stock plan registration | Feb 27, 2025 | — |
| 10-K | Annual report | Feb 27, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2025 | Aug 10, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 10-Q | Quarterly report | Nov 6, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 6, 2024 | Nov 6, 2024 |
| 10-Q | Quarterly report | Aug 7, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2024 | Aug 7, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 6, 2024 | Jun 5, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 23, 2024 | May 23, 2024 |
| 10-Q | Quarterly report | May 8, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 8, 2024 | May 8, 2024 |
| ARS | Annual report to shareholders | Apr 29, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Apr 29, 2024 | Dec 31, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 17, 2024 | Jun 5, 2024 |
| S-8 | Employee stock plan registration | Mar 18, 2024 | — |
| 10-K | Annual report | Mar 18, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 18, 2024 | Mar 18, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 7, 2024 | Feb 7, 2024 |
| 10-Q | Quarterly report | Nov 8, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2023 | Nov 8, 2023 |
| EFFECT | Filing | Sep 11, 2023 | — |
| CORRESP | Letter to the SEC | Sep 7, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 7, 2023 | — |
| S-3 | Shelf registration | Sep 1, 2023 | — |
| 8-K |
Current report
Officer or director change
|
Aug 30, 2023 | Aug 28, 2023 |
| D | Filing | Aug 24, 2023 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Aug 10, 2023 | Aug 10, 2023 |
| 10-Q | Quarterly report | Aug 7, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Aug 7, 2023 | Aug 3, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 7, 2023 | Jun 6, 2023 |
| 10-Q | Quarterly report | May 9, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 9, 2023 | May 9, 2023 |
| ARS | Annual report to shareholders | Apr 24, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 24, 2023 | — |
| DEF 14A | Proxy statement | Apr 24, 2023 | Jun 6, 2023 |
| 10-K | Annual report | Mar 27, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 27, 2023 | Mar 27, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Feb 28, 2023 | Feb 27, 2023 |
| S-8 | Employee stock plan registration | Feb 7, 2023 | — |
| 10-Q | Quarterly report | Nov 10, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2022 | Nov 10, 2022 |
| EFFECT | Filing | Sep 28, 2022 | — |
| POS AM | Filing | Sep 21, 2022 | — |
| EFFECT | Filing | Sep 12, 2022 | — |
| CORRESP | Letter to the SEC | Sep 8, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 7, 2022 | — |
| S-3 | Shelf registration | Sep 1, 2022 | — |
| 424B3 | Prospectus | Aug 10, 2022 | — |
| 10-Q | Quarterly report | Aug 10, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2022 | Aug 10, 2022 |
| 424B3 | Prospectus | Jun 10, 2022 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2022 | Jun 8, 2022 |
| 424B3 | Prospectus | May 11, 2022 | — |
| 10-Q | Quarterly report | May 11, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 11, 2022 | May 11, 2022 |
| DEFA14A | Additional proxy material | Apr 26, 2022 | — |
| DEF 14A | Proxy statement | Apr 26, 2022 | Jun 8, 2022 |
| EFFECT | Filing | Mar 31, 2022 | — |
| POS AM | Filing | Mar 28, 2022 | — |
| S-8 | Employee stock plan registration | Mar 28, 2022 | — |
| 10-K | Annual report | Mar 28, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 28, 2022 | Mar 28, 2022 |
| 424B3 | Prospectus | Nov 9, 2021 | — |
| 10-Q | Quarterly report | Nov 9, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2021 | Nov 9, 2021 |
| S-8 | Employee stock plan registration | Oct 14, 2021 | — |
| 424B3 | Prospectus | Oct 8, 2021 | — |
| EFFECT | Filing | Sep 29, 2021 | — |
| 424B3 | Prospectus | Sep 29, 2021 | — |
| CORRESP | Letter to the SEC | Sep 27, 2021 | — |
| UPLOAD | Letter from the SEC | Sep 17, 2021 | — |
| S-1 | Registration statement | Sep 10, 2021 | — |
| 8-K |
Current report
Acquisition or sale of assets, Change to shareholder rights, Auditor change, Change in control, Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Aug 13, 2021 | Aug 10, 2021 |
| 10-Q | Quarterly report | Aug 9, 2021 | Jun 30, 2021 |
| 424B3 | Prospectus | Jul 19, 2021 | — |
| SEC STAFF LETTER | Filing | Jul 16, 2021 | — |
| EFFECT | Filing | Jul 16, 2021 | — |
| S-4/A | Amendment no. 3 to form s-4 | Jul 16, 2021 | — |
| CORRESP | Letter to the SEC | Jul 15, 2021 | — |
| S-4/A | Amendment no. 2 to form s-4 | Jul 6, 2021 | — |
| CORRESP | Letter to the SEC | Jul 2, 2021 | — |
| UPLOAD | Letter from the SEC | Jun 30, 2021 | — |
| SEC STAFF LETTER | Filing | Jun 23, 2021 | — |
| CORRESP | Letter to the SEC | Jun 17, 2021 | — |
| S-4/A | Registration statement | Jun 17, 2021 | — |
| UPLOAD | Letter from the SEC | May 17, 2021 | — |
| 10-Q | Quarterly report | May 14, 2021 | Mar 31, 2021 |
| S-4 | Registration for a merger or exchange | Apr 20, 2021 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Apr 14, 2021 | Apr 13, 2021 |
| 425 | Current report | Apr 14, 2021 | — |
| 10-K | Annual report | Mar 31, 2021 | Dec 31, 2020 |
| 10-Q | Quarterly report | Nov 13, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Officer or director change
|
Oct 7, 2020 | Oct 6, 2020 |
| 8-K |
Current report
Other events
|
Sep 14, 2020 | Sep 8, 2020 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
|
Sep 9, 2020 | Sep 2, 2020 |
| 424B4 | Prospectus | Sep 4, 2020 | — |
| CERT | Filing | Sep 3, 2020 | — |
| EFFECT | Filing | Sep 2, 2020 | — |
| S-1MEF | Registration statement | Sep 2, 2020 | — |
| 8-A12B | For registration of certain classes of securities | Sep 2, 2020 | — |
| S-1/A | Amended registration statement | Aug 31, 2020 | — |
| S-1 | Registration statement | Jul 30, 2020 | — |
Showing 156 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TNGX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1819133
- Former names
- BCTG Acquisition Corp. (until Aug 9, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.